Mainstreet Health Investments Inc (TSE:HLP.U) had its price objective lowered by investment analysts at National Bank Financial from C$9.50 to C$9.00 in a note issued to investors on Tuesday. The brokerage currently has a “sector perform” rating on the stock.
Separately, BMO Capital Markets reaffirmed an “outperform” rating and set a C$11.25 price target on shares of Mainstreet Health Investments in a research note on Thursday, August 17th.
What are top analysts saying about Mainstreet Health Investments Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mainstreet Health Investments Inc and related companies.